Development of nanobody-displayed whole-cell biosensors for the colorimetric detection of SARS-CoV‑2
The accurate and effective detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is essential to preventing the spread of infectious diseases and ensuring human health. Herein, a nanobody-displayed whole-cell biosensor was developed for colorimetric detection of SARS-CoV-2 spike...
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | info:ar-repo/semantics/artículo |
| Lenguaje: | Inglés |
| Publicado: |
American Chemical Society
2023
|
| Materias: | |
| Acceso en línea: | http://hdl.handle.net/20.500.12123/15222 https://pubs.acs.org/doi/10.1021/acsami.3c05900 https://doi.org/10.1021/acsami.3c05900 |
Ejemplares similares: Development of nanobody-displayed whole-cell biosensors for the colorimetric detection of SARS-CoV‑2
- SPR Biosensing MUA/Poly-L-lysine platform for the detection of 2,4-Dinitrophenol as small molecule model system
- SARS-CoV-2 specific nanobodies neutralize different variants of concern and reduce virus load in the brain of h-ACE2 transgenic mice
- Hacia una vacuna contra el Coronavirus causante de la Covid-19
- Characterization of the SARS-CoV-2 Mutation Pattern Generated In Vitro by the Antiviral Action of Lycorine
- Antibodies to SARS-CoV2 induced by vaccination and infection correlate with protection against the infection
- El desafío de entender qué es el SARS-CoV-2